Trillium Trading, LLC 披露被动持股：截至6月3日持有WORK Medical Technology Group 18.0%股份

美股速递

Jun 09

根据一份提交给美国证券交易委员会（SEC）的文件，Trillium Trading, LLC 已披露其被动持股情况。截至2024年6月3日，该公司持有WORK Medical Technology Group, Ltd. 18.0%的股份。

这一持股比例意味着Trillium Trading已成为WORK Medical Technology Group的重要股东。根据美国证券法规，当一家机构持有上市公司超过5%的股份时，通常需要向SEC提交相关文件披露其持股细节及意图。

文件明确指出，Trillium Trading此次申报的持股性质为“被动投资”。这通常表明该投资机构目前无意寻求对公司施加控制性影响或推动其业务战略发生重大改变。被动投资策略通常着眼于长期价值增长，而非短期干预公司运营。

市场分析人士指出，此类机构投资者的增持行为，往往被视作对公司长期发展前景抱有信心的信号。WORK Medical Technology Group作为医疗技术领域的企业，其业务表现与行业创新动态紧密相连。重要股东结构的变动，可能引发市场对其未来资本运作或战略方向的进一步关注。

目前，WORK Medical Technology Group及Trillium Trading均未就此次持股披露发表额外评论。投资者将继续关注后续可能出现的任何股权变动或公司公告。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1192726452"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192726452\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192726452?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-06-09 03:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192726452","market":"us","top_or_hot":-1,"title":"Trillium Trading, LLC 披露被动持股：截至6月3日持有WORK Medical Technology Group 18.0%股份","media":"美股速递","content":"<p>根据一份提交给美国证券交易委员会（SEC）的文件，Trillium Trading, LLC 已披露其被动持股情况。截至2024年6月3日，该公司持有WORK Medical Technology Group, Ltd. 18.0%的股份。</p>\n<p>这一持股比例意味着Trillium Trading已成为WORK Medical Technology Group的重要股东。根据美国证券法规，当一家机构持有上市公司超过5%的股份时，通常需要向SEC提交相关文件披露其持股细节及意图。</p>\n<p>文件明确指出，Trillium Trading此次申报的持股性质为“被动投资”。这通常表明该投资机构目前无意寻求对公司施加控制性影响或推动其业务战略发生重大改变。被动投资策略通常着眼于长期价值增长，而非短期干预公司运营。</p>\n<p>市场分析人士指出，此类机构投资者的增持行为，往往被视作对公司长期发展前景抱有信心的信号。WORK Medical Technology Group作为医疗技术领域的企业，其业务表现与行业创新动态紧密相连。重要股东结构的变动，可能引发市场对其未来资本运作或战略方向的进一步关注。</p>\n<p>目前，WORK Medical Technology Group及Trillium Trading均未就此次持股披露发表额外评论。投资者将继续关注后续可能出现的任何股权变动或公司公告。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trillium Trading, LLC 披露被动持股：截至6月3日持有WORK Medical Technology Group 18.0%股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrillium Trading, LLC 披露被动持股：截至6月3日持有WORK Medical Technology Group 18.0%股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-06-09 03:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>根据一份提交给美国证券交易委员会（SEC）的文件，Trillium Trading, LLC 已披露其被动持股情况。截至2024年6月3日，该公司持有WORK Medical Technology Group, Ltd. 18.0%的股份。</p>\n<p>这一持股比例意味着Trillium Trading已成为WORK Medical Technology Group的重要股东。根据美国证券法规，当一家机构持有上市公司超过5%的股份时，通常需要向SEC提交相关文件披露其持股细节及意图。</p>\n<p>文件明确指出，Trillium Trading此次申报的持股性质为“被动投资”。这通常表明该投资机构目前无意寻求对公司施加控制性影响或推动其业务战略发生重大改变。被动投资策略通常着眼于长期价值增长，而非短期干预公司运营。</p>\n<p>市场分析人士指出，此类机构投资者的增持行为，往往被视作对公司长期发展前景抱有信心的信号。WORK Medical Technology Group作为医疗技术领域的企业，其业务表现与行业创新动态紧密相连。重要股东结构的变动，可能引发市场对其未来资本运作或战略方向的进一步关注。</p>\n<p>目前，WORK Medical Technology Group及Trillium Trading均未就此次持股披露发表额外评论。投资者将继续关注后续可能出现的任何股权变动或公司公告。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WOK","symbol_name":"WORK Medical Technology Group, Ltd.","start_time":0,"source_url":"","article_id":"1192726452","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192726452","pubTimestamp":1780946060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"根据一份提交给美国证券交易委员会的文件，Trillium Trading, LLC 已披露其被动持股情况。截至2024年6月3日，该公司持有WORK Medical Technology Group, Ltd. 18.0%的股份。这一持股比例意味着Trillium Trading已成为WORK Medical Technology Group的重要股东。文件明确指出，Trillium Trading此次申报的持股性质为“被动投资”。WORK Medical Technology Group作为医疗技术领域的企业，其业务表现与行业创新动态紧密相连。目前，WORK Medical Technology Group及Trillium Trading均未就此次持股披露发表额外评论。投资者将继续关注后续可能出现的任何股权变动或公司公告。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"WOK":"WORK Medical Technology Group, Ltd.","BK4198":"医疗保健用品"},"translate_title":"Trillium Trading, LLC Discloses Passive Holdings: 18.0% Stake in WORK Medical Technology Group as of June 3","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WOK":1},"content_text":"根据一份提交给美国证券交易委员会（SEC）的文件，Trillium Trading, LLC 已披露其被动持股情况。截至2024年6月3日，该公司持有WORK Medical Technology Group, Ltd. 18.0%的股份。\n这一持股比例意味着Trillium Trading已成为WORK Medical Technology Group的重要股东。根据美国证券法规，当一家机构持有上市公司超过5%的股份时，通常需要向SEC提交相关文件披露其持股细节及意图。\n文件明确指出，Trillium Trading此次申报的持股性质为“被动投资”。这通常表明该投资机构目前无意寻求对公司施加控制性影响或推动其业务战略发生重大改变。被动投资策略通常着眼于长期价值增长，而非短期干预公司运营。\n市场分析人士指出，此类机构投资者的增持行为，往往被视作对公司长期发展前景抱有信心的信号。WORK Medical Technology Group作为医疗技术领域的企业，其业务表现与行业创新动态紧密相连。重要股东结构的变动，可能引发市场对其未来资本运作或战略方向的进一步关注。\n目前，WORK Medical Technology Group及Trillium Trading均未就此次持股披露发表额外评论。投资者将继续关注后续可能出现的任何股权变动或公司公告。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}